Shire

M&A buzz: ViroPharma could go for $60 per share in buyout
Fierce Biotech
Fri, 09/20/13 - 12:42 pm
Sanofi
Shire
M&A
ViroPharma
Analyst Sees Big Risks Lurking in Possible Biotech Buyout
Yahoo/24-7 Wall St
Wed, 09/18/13 - 12:44 pm
ViroPharma
Sanofi
M&A
Shire
A Closer Look at the Controversial Market Growth of ADHD Treatments
Motley Fool
Wed, 08/28/13 - 04:49 pm
ADHD
Shire
Adderall
Strattera
Eli Lilly
JNJ
Novartis
Concerta
Ritalin
Shire hired Lazard to fend off takeovers, SundayTimes reports
Yahoo/Fly on the Wall
Mon, 08/19/13 - 09:45 am
Shire
M&A
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
R&D
AstraZeneca
Bayer
Eli Lilly
Novartis
Pfizer
Regeneron
Roche
Shire
Takeda
Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
FT.com
Mon, 07/29/13 - 01:39 pm
Shire
Vertex Pharmaceuticals
Biomarin
orphan drugs
Orphan Drug Tax Credit
Keryx Biopharmaceuticals' Zerenex Likely To Receive FDA Approval
Seeking Alpha
Mon, 07/22/13 - 05:58 pm
Keryx
FDA
Zerenex
Sanofi
Shire
hyperphosphatemia
An Interesting Bio Play in the Blood Disorder Niche
Motley Fool
Tue, 07/2/13 - 01:39 am
hereditary angiodema
Dyax
Shire
CSL
ViroPharma
Biovitrum
Halozyme
Cinryze
Shire’s New CEO Adds Sales Staff, Damps Takeover Talk
Bloomberg
Mon, 06/10/13 - 06:00 am
Pharma CEOs
Shire
hirings
Flemming Ornskov
Shire Licenses Teva To Sell Genereic Version Of INTUNIV Treatment For ADHD
Jewish Business
Sun, 06/9/13 - 09:47 am
Shire
generics
Intuniv
treatment
Teva Pharmaceuticals
ADHD
A Jilted Shire Exec, Age Discrimination And A Federal Probe?
Pharmalot
Thu, 05/30/13 - 11:28 am
Shire
age discrimination
DOJ
Shire may return cash to thwart takeover, Daily Mail reports
Yahoo/Fly on the Wall
Mon, 05/20/13 - 09:50 am
Shire
M&A
Bristol-Myers Squibb
Shire cuts sales forecast as some drugs miss Q1 targets
Reuters
Thu, 05/2/13 - 10:29 am
earnings
Shire
Why GlaxoSmithKline Beats AstraZeneca and Shire
Motley Fool
Sat, 04/13/13 - 12:08 pm
GSK
AstraZeneca
Shire
Why GlaxoSmithKline Beats AstraZeneca and Shire
Motley Fool
Fri, 04/12/13 - 01:24 pm
GSK
Shire
AstraZeneca
ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity
Seeking Alpha
Wed, 04/3/13 - 10:55 am
ViroPharma
Dyax
Shire
Halozyme
generics
Shire to Buy Eye-Drug Maker SARcode for $160 Million
Bloomberg
Tue, 03/26/13 - 10:18 am
SARcode
M&A
Shire
Shire buys Premacure and its infant eye drug
Pharma Times, UK
Wed, 03/13/13 - 10:50 am
Shire
Premacure
M&A
Bristol-Myers might just make a big deal, WSJ says
Fierce Pharma
Tue, 03/5/13 - 12:01 pm
Bristol-Myers Squibb
M&A
Biogen Idec
Shire
Teva Announces FDA Approval of Generic Adderall XR®
Yahoo
Thu, 02/14/13 - 10:35 am
FDA
generics
Teva
Adderall ZR
Shire
ADHD

Pages